Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The phrase they kept repeating ‘we’re taking multiple shots on goal’ was goofy. They need a better script writer.
True but that doesn’t account for the different tax treatments between short and long term gains or the trading fees or the time required to make daily trades vs one trade.
Stock dropping hard in after hours.
Roth capital asking questions on the call. Hopefully they maintain coverage.
800-860-2442 to listen live.
They’re just restating trial plans.
They did mention that fda fast track makes approval possible before phase III trials.
However best guess at timeline for drug to be available is 2022.
So far no new info. Kind of boring
Wow. Somebody dumped their holdings. Too bad. We were fairly steady at 6. Now back down in the 3’s.
Nobody here should feel responsible for anybody jumping in or out of a stock. It’s just an opinion board. Everyone should do their due diligence and make their own decisions.
This board has both positive and negative opinions on what might happen which proves that nobody here really knows. But it’s fun to speculate LOL.
Premarket looks a little higher around 1.65.
The stock might move sideways while everyone waits for the conference call.
It really all depends on what they reveal on the conference call. It nothing new I think the stock tanks. If significant discovery really is significant the stock could fly.
Now we wait for 7 hours to find out.
Thanks. That confirms what we saw yesterday based on market cap. Almost 34M shares outstanding after the March offering. This new direct offering will add approx 10M plus 5M if the warrants are exercised. So there would be about 49M shares outstanding if all warrants exercised. It’s not great to see the dilution but 49M shares for a startup biotech isn’t bad comparatively speaking.
Lol. It’s an interesting theory. Anything could happen. It will be interesting whatever it is.
I agree. They probably set up the deal when the stock was around $1 and justified the higher price for the offering based on early data that they presented to the institutions. It’s also possible that much of the buying yesterday was by people connected to the deal and in the know about the data.
The volume yesterday was much higher than today so in theory only a portion of new holders unloaded their position.
I think this may tread water tomorrow while everyone waits for the conference call.
It’s really a toss up in my opinion. Why wait until after hours if the news is good? Often an after hours announcement is timed to minimize impact of disappointing news.
We’ll know for sure in 24 hours.
Whichever way it goes it will be exciting to watch.
Lol. Thanks
The market cap divided by share price on iHub and yahoo both imply 34M OS. Perhaps the company the clarify on the conference call tomorrow.
Does anyone know which institutions purchased the latest offering? Perhaps they’re more positive indication than sabby.
I think you’re correct. They were issued prior to the lung cancer and fda fast track announcements. But they also exclude impact from the last 2 offerings. They are due for an update.
Based on current market cap it looks to be around 34M. I think the float is around 16M.
Latest info I can find
Roth capital has target price of $8
Maxim has price target of $3
That is a good point. They agreed to the $1.60 level when the stock was trading far below that price. They must have seen information to give them confidence that the stock would achieve much higher levels than the current price today.
It was incredibly stupid of the company to do 2 offerings in such a short time period. Hopefully with the new funds and FDA fast track they can deliver meaningful results this year and the stock will recover.
It’s sinking fast
They just killed the rally. Great timing.
It’s never a bad move to take some profit off the table. This can go down just as fast as it went up. Look at the history. It went above $3 a couple years ago then recently sank below $1.
I also never expected to see this stock in the pennies when I first invested in it. I was sold on the science and the potential of the growing patent portfolio. But here we are.
I’m grateful it’s still alive. As of 5 years ago I thought it might be dead before today.
Based on what’s happening with another stock I have I’m getting renewed optimism with this one. It proves anything is possible with penny stocks.
The lack of comms is frustrating so all we can do is wait and hope they’re making progress toward some deals with intel and other infringers.
You were right. I can’t believe it’s all based on last week’s news though. Something else must be happening. Short squeeze?
Anybody know what’s going on today? This is crazy.
If that were true why isn’t there a bid? How can anyone sell shares cheap without a bid?
To the contrary there are consistently hundreds of millions of shares for sale but no buyer.
Correction to my precious post.
I stated that the share price was stuck at 0.0001. It’s actually worse. The price is now at 0.000001. That’s 5 zeroes. I don’t think that 6 zeroes is possible but you never know this stock might break new ground.
They’re just exploring options. Nothing to see here.
And one day it can rain while the next day it can be sunny. So?
Even if all of that were true, it hasn’t affected the share price or benefitted shareholders at all, year after year.
Here come the 4’s
Wow. Another gap up. Hopefully it holds this time.
Great news. Huge potential. Looks like a gap up this morning over $1.
The problem however is that it’s difficult for investors to see when annamycin might actually be ready for generating revenue.
It's eerily quiet. Without filings, company comms, analyst coverage, etc all we can do is sit and wait and hope for the best. It would be nice to at least get an update on the NEO case.
For now at least the share price seems steady around the 6 cent level.
I don’t think it’s unlikely.
The psychology behind these failed stocks is fascinating.
Either way it doesn’t really matter why anyone posts here. The facts are the same. The stock has been stuck at .0001 for years. Every prediction over the past decade about some big profitable deal has been wrong.
The excuses have been entertaining. First it was waiting for the deal to be finalized. After a couple years of that it was waiting for the end of the tax year. A few more years of that and then it was waiting for Telogis to go public. That didn’t happen so the new excuse was that Verizon planned to create a spinoff.
Reasons for the depressed share price are equally creative. First it was being shorted. When no proof of that could be found the reason was existence of phantom shares, which of course couldn’t be proven either. Then there was the idea that market makers were holding it down so they could accumulate shares.
Finally the best reply anyone could muster was weeeeeeeeeee and $$$$$$$$$$$.
Meanwhile the reason for 0.0001 was revealed by the company in very plain terms years and years ago. They couldn’t pay the loans so creditors sold the assets held as collateral.
End of story.
Probably just interested in stock scams